跳至主要内容
临床试验/NCT02273323
NCT02273323已完成不适用

Flow Mediated Dilation in Response to Consumption of Black Tea Versus Artificial Tea, in Non-tea Drinking Hypertensive Subjects.

Unilever R&D2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2014年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
试验地点
2
主要终点
Flow Mediated Dilation

研究概览

简要总结

Research indicate that people who regularly drink tea have a reduced risk of stroke or heart disease. In a number of studies in which people that normally do not drink showed that their blood vessels function improved when the drunk tea. The current study tests whether a specific black tea improves vessel function in non-tea drinking hypertensive subjects.

详细描述

Epidemiological studies indicate that regular consumption of three cups of black tea per day reduces the risk of stroke or myocardial infarction. In a number of previous nutrition intervention studies tea has been shown to improve vascular function as assessed by Flow Mediated Dilation in various populations. The current confirmatory study tests a specific black tea against a placebo in a population of in non-tea drinking hypertensive subjects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males and post menopausal (> 1 year) females, not on hormone replacement therapy
  • Aged >18 and < 65 years
  • Body mass index (BMI) of >=18.0 and =<35.0 kg/m2
  • Hypertension as previously diagnosed by primary care or hospital physician.
  • If untreated, office BP between 140/90 mmHg and 160/100 mmHg on screening
  • If treated, a controlled blood pressure (<160/100) on stable medication for at least 4 weeks

排除标准

  • Tea drinkers: having typically consumed > 1 cup of black tea per week.
  • Current smoker or has stopped smoking less than 6 months before start of study
  • Self reported alcohol intake of >21 units/week
  • Established cardiovascular disease other than hypertension
  • Clinically significant arrhythmia
  • Diabetes mellitus
  • Chronic Kidney Disease > stage 2
  • 10-year cardiovascular risk equivalent to 20% or greater using the QRisk2 calculator
  • Abnormality of laboratory blood tests considered clinically significant
  • Any other significant intercurrent condition/disease

结局指标

主要结局

Flow Mediated Dilation

时间窗: Before and 2 hours after test product intake

Flow mediated dilation (FMD) of the brachial artery was measured using vascular ultra sound and automated edge detection software: * 1 minute baseline scan to measure the baseline diameter of artery * 5 minutes of forearm occlusion at 250±30 mmHg, below the elbow (2-5 cm from antecubital crease) * 4 minutes FMD scan, which started immediately after release of occlusion Percentage FMD was calculated as the maximum increase in diameter after cuff release relative to the baseline diameter

次要结局

  • Systolic Blood Pressure Supine(Before and 110 minutes after test product intake)
  • Systolic Blood Pressure Sitting(Before and 90 minutes after test product intake)
  • Diastolic Blood Pressure Sitting(Before and 90 minutes after test product intake)
  • Diastolic Blood Pressure Supine(Before and 110 minutes after test product intake)
  • Endothelium-independent Vasodilation(2.5 hours after test product intake)

研究者

发起方
Unilever R&D
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验